Product NDC: | 67877-215 |
Proprietary Name: | Cefuroxime axetil |
Non Proprietary Name: | Cefuroxime axetil |
Active Ingredient(s): | 250 mg/1 & nbsp; Cefuroxime axetil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67877-215 |
Labeler Name: | Ascend Laboratories, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065496 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101201 |
Package NDC: | 67877-215-20 |
Package Description: | 20 TABLET, FILM COATED in 1 BOTTLE (67877-215-20) |
NDC Code | 67877-215-20 |
Proprietary Name | Cefuroxime axetil |
Package Description | 20 TABLET, FILM COATED in 1 BOTTLE (67877-215-20) |
Product NDC | 67877-215 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefuroxime axetil |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20101201 |
Marketing Category Name | ANDA |
Labeler Name | Ascend Laboratories, LLC |
Substance Name | CEFUROXIME AXETIL |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |